Steris (STE) Free Cash Flow Growth (3y) (2021 - 2026)
Steris (STE) Free Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 9.23% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 16.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.23% |
| Mar 31, 2026 | 19.32% |
| Dec 31, 2025 | 20.59% |
| Sep 30, 2025 | 112.24% |
| Jun 30, 2025 | 41.25% |
| Mar 31, 2025 | 24.39% |
| Dec 31, 2024 | 14.29% |
| Sep 30, 2024 | 16.42% |
| Jun 30, 2024 | 68.30% |
| Mar 31, 2024 | 13.04% |
| Dec 31, 2023 | 4.28% |
| Sep 30, 2023 | -18.98% |
| Jun 30, 2023 | 47.20% |
| Mar 31, 2023 | 1.42% |
| Dec 31, 2022 | 14.47% |
| Sep 30, 2022 | -40.96% |
| Jun 30, 2022 | 24.83% |
| Mar 31, 2022 | -1.25% |
| Dec 31, 2021 | 25.18% |
| Sep 30, 2021 | 1.18% |